Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |